Published in J Invest Dermatol on December 01, 1987
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A (1990) 5.26
Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest (1992) 4.40
Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest (1998) 4.00
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev (2008) 3.46
Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol (1989) 2.58
Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J (2009) 2.48
alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. J Cell Biol (1997) 2.46
Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J (2000) 2.44
The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol (2002) 2.22
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
Stimulation of fascin spikes by thrombospondin-1 is mediated by the GTPases Rac and Cdc42. J Cell Biol (2000) 1.53
The thrombospondins. Cold Spring Harb Perspect Biol (2011) 1.52
Thrombospondin 1 synthesis and function in wound repair. Am J Pathol (1996) 1.52
Thrombospondin modulates alpha v beta 3 function through integrin-associated protein. J Cell Biol (1996) 1.43
Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1. Mol Biol Cell (1994) 1.35
Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med (2003) 1.32
Chinese hamster ovary cell adhesion to human platelet thrombospondin is dependent on cell surface heparan sulfate proteoglycan. J Clin Invest (1989) 1.32
Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J Cell Biol (1995) 1.30
Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol (1988) 1.29
Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms. Matrix Biol (2012) 1.23
Thrombospondin stimulates motility of human neutrophils. J Cell Biol (1990) 1.20
The role of thrombospondins in wound healing, ischemia, and the foreign body reaction. J Cell Commun Signal (2009) 1.11
Aging-associated changes in renal extracellular matrix. Am J Pathol (1995) 1.06
Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. FASEB J (2008) 1.05
Thrombospondin deposition in rat carotid artery injury. Am J Pathol (1990) 1.00
Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. J Clin Invest (1991) 1.00
Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis. Am J Pathol (1994) 0.97
Invoking the power of thrombospondins: regulation of thrombospondins expression. Matrix Biol (2014) 0.92
Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis. PLoS One (2012) 0.87
Activation of Latent TGF-β1 by Thrombospondin-1 is a Major Component of Wound Repair. Oral Biosci Med (2005) 0.86
Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol Cancer Ther (2009) 0.83
Dynamic expression of two thrombospondins during axolotl limb regeneration. Dev Dyn (2011) 0.83
TNFα induces inflammatory stress response in microvascular endothelial cells via Akt- and P38 MAP kinase-mediated thrombospondin-1 expression. Mol Cell Biochem (2015) 0.81
Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours. J Clin Pathol (1999) 0.77
Thrombospondin receptor expression in human neutrophils coincides with the release of a subpopulation of specific granules. Biochem J (1992) 0.77
Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance. J Cell Mol Med (2009) 0.75
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet (1997) 4.72
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol (1986) 4.51
Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol (1991) 4.48
Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation (1994) 4.32
Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol (1989) 3.43
Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. Am J Pathol (1995) 3.37
Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science (1990) 3.27
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. J Clin Oncol (1999) 3.04
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement. Am J Clin Pathol (2000) 2.53
Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies. J Cell Biol (1982) 2.45
Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol (1984) 2.42
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis (1986) 2.27
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27
Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol (1986) 2.26
Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem (1997) 1.99
Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol (1989) 1.87
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer. J Clin Oncol (1999) 1.77
Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene (1999) 1.73
PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell (1991) 1.67
Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. Am J Clin Pathol (1989) 1.65
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 1.63
Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb (1992) 1.59
HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. Am J Pathol (1987) 1.58
Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol (1992) 1.57
Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest (1993) 1.56
Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem (1995) 1.55
Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol (2000) 1.52
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol (2001) 1.51
Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet (1996) 1.50
Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. Am J Clin Pathol (1985) 1.50
Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing? Breast Cancer Res Treat (2011) 1.47
Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int (1992) 1.46
Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem (1999) 1.44
Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol (1985) 1.40
Incidence of acute exertional rhabdomyolysis. Serum myoglobin and enzyme levels as indicators of muscle injury. Arch Intern Med (1976) 1.38
Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol (1999) 1.38
Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol (1998) 1.38
Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med (2001) 1.37
Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications. Arch Dermatol (1998) 1.37
Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver. Proc Natl Acad Sci U S A (1997) 1.35
Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol (2000) 1.34
P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol (2002) 1.33
Atheroma: the artery wall and the environment. Int Rev Exp Pathol (1980) 1.30
Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma. Cancer Res (1995) 1.29
The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod Pathol (1991) 1.28
Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol (1993) 1.20
Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol (2001) 1.19
The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med (1999) 1.18
Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol (1992) 1.18
Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins. Lab Invest (1984) 1.17
Characterization of two monoclonal antibodies to human epidermal keratohyalin: reactivity with filaggrin and related proteins. J Invest Dermatol (1987) 1.17
PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem (1991) 1.15
P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol (2004) 1.13
Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol (1996) 1.12
Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med (2000) 1.11
Various cell types in human atherosclerotic lesions express ICAM-1. Further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol (1992) 1.10
Absence of active cutaneous vasodilation associated with congenital absence of sweat glands in humans. Am J Physiol (1981) 1.09
Epidermal and dermal integration into sphere-templated porous poly(2-hydroxyethyl methacrylate) implants in mice. J Biomed Mater Res A (2010) 1.08
Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem (1992) 1.08
Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol (1998) 1.08
Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Invest (1993) 1.06
Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. Am J Physiol (1998) 1.05
Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol (1992) 1.05
Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J Toxicol Environ Health (1981) 1.05
Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications. Am J Surg (1986) 1.04
Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol (1989) 1.04
Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression. Mod Pathol (1996) 1.03
Color subtractive-computer-assisted image analysis for quantification of cutaneous nerves in a diabetic mouse model. J Histochem Cytochem (2001) 1.03
Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol (1998) 1.01
Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer. Gynecol Oncol (2000) 1.01
Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. Am J Pathol (1988) 1.00
Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Differ (1992) 1.00
Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol (1992) 1.00
Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 0.99
Cell proliferation after balloon injury of iliac arteries in the cholesterol-fed New Zealand White rabbit. Arterioscler Thromb (1994) 0.98
VCAM-1 expression on human dermal microvascular endothelial cells is directly and specifically up-regulated by substance P. J Immunol (1999) 0.98
The fibroblast-like nature of myofibroblasts. Exp Mol Pathol (1988) 0.97
Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study. Virchows Arch (1999) 0.97
Detection of cell proliferation in tissue sections. Braz J Med Biol Res (1993) 0.97
A mouse model to evaluate the interface between skin and a percutaneous device. J Biomed Mater Res A (2007) 0.97
Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J Immunol (2001) 0.96
Coexpression of intermediate filaments in human epithelial neoplasms. Ultrastruct Pathol (1985) 0.96
CGA-7 and HHF, two monoclonal antibodies that recognize muscle actin and react with adherent cells in human long-term bone marrow cultures. Blood (1985) 0.96
A monoclonal antibody against nerve growth factor receptor. Immunohistochemical analysis of normal and neoplastic human tissue. Am J Clin Pathol (1989) 0.96
Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol (1999) 0.95
Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients. Cancer (1989) 0.94
Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus. Virchows Arch (1995) 0.93
Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with S-100 protein in paraffin sections. Cancer (1988) 0.92
Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol (1987) 0.92
Overexpression of p53 in head and neck cancer. Head Neck (1993) 0.91
Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. Lab Invest (1991) 0.91
Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R). Exp Dermatol (2000) 0.91
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol (2001) 0.91
Metabolism of very-low-density lipoprotein triglyceride by human placental cells: the role of lipoprotein lipase. Metabolism (1992) 0.91
Activation of B lymphocyte maturation by a human follicular dendritic cell line, FDC-1. J Immunol (1995) 0.90
Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas. Mod Pathol (1990) 0.89